The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart ... intervention like a regular generic drug.

28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill cartridge Novolog Mix 70/30 pen fill cartridge (Novo Nordisk ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Experts aren’t really on board with taking these new, buzzy, multi-ingredient supplements that claim to help with insulin ...

Income Tax department has completed the regular assessment under Section 143(3) and passed assessment order pertaining to AY ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

The Scheme does not guarantee/ indicate any returns. The Baroda BNP Paribas Large Cap Fund Regular Plan Growth has an AUM of 2262.51 crores & has delivered CAGR of 24.47% in the last 5 years.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks for adults with type 1 diabetes, according to findings from ...

"I like it because it tickles," he says, and imagines that now a regular toothbrush would feel "yucky" in his mouth. Nicholas isn't the only kid who prefers the powered devices. Eileen Hermiston ...